110 results on '"Richette, P."'
Search Results
2. POS1077 LARGE JOINT INVOLVEMENT AND SUBSTANTIAL DISEASE BURDEN IN PATIENTS WITH OLIGOARTICULAR AND POLYARTICULAR PSORIATIC ARTHRITIS IN THE MULTINATIONAL UPLIFT SURVEY
3. POS1165 ASSOCIATION OF LDHD RARE VARIANTS WITH EARLY-ONSET GOUT IN TWO FAMILIES WITH AN ADDITIONAL ASSOCIATION OF RHBG VARIANT IN ONE.
4. POS1055 IDENTIFICATION OF PsA PHENOTYPES WITH MACHINE LEARNING ANALYTICS USING DATA FROM A PHASE 3 CLINICAL TRIAL PROGRAMME OF GUSELKUMAB IN A BIO-NAÏVE PATIENT POPULATION
5. POS0309 ARE PATIENTS’ AND RHEUMATOLOGISTS’ PERCEPTIONS OF THE BURDEN AND TREATMENT OF PSORIATIC ARTHRITIS ALIGNED? RESULTS FROM THE UPLIFT SURVEY
6. OP0259 MINIMAL DISEASE ACTIVITY RESPONSE PATTERNS IN BIO-NAIVE PATIENTS TREATED WITH GUSELKUMAB: A MACHINE LEARNING ANALYSIS
7. OP0066 IMPACT OF DIAGNOSIS AND TREATMENT OF TROPHERYMA WHIPPLEI INFECTION IN PATIENTS WITH PRE-EXISTING CHRONIC INFLAMMATORY RHEUMATIC DISEASES: DATA FROM THE NATIONAL Tw-IRD REGISTRY
8. POS1161 CAN DOCTORS TREAT GOUT WELL? INSIGHT ON GOUT MANAGEMENT IN REFERRAL CENTRES
9. POS0993 RADIOLOGICAL CERVICAL INVOLVMENT IN ANKYLOSING SPONDYLITIS
10. POS1169 THE INFLAMMATION INDUCED BY MONOSODIUM URATE AND CALCIUM PYROPHOSPHATE CRYSTALS DEPENDS ON OSMOLARITY AND AQUAPORIN CHANNELS.
11. POS1035 UPADACITINIB AS MONOTHERAPY AND IN COMBINATION WITH NON-BIOLOGIC DMARDs FOR THE TREATMENT OF PSORIATIC ARTHRITIS: SUBGROUP ANALYSIS FROM TWO PHASE 3 TRIALS
12. POS1032 EFFICACY OF UPADACITINIB IN PATIENTS WITH PSORIATIC ARTHRITIS STRATIFIED BY NUMBER OF PRIOR BIOLOGIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS
13. POS1124 IDENTIFYING POTENTIAL CLASSIFICATION CRITERIA FOR CALCIUM PYROPHOSPHATE DEPOSITION DISEASE (CPPD): RESULTS FROM THE INITIAL PHASES
14. OP0298 ARE PATIENTS WITH PSORIATIC ARTHRITIS BEING TREATED OPTIMALLY ACROSS THE WORLD? DISPARITIES IN HEALTH CARE FOR PATIENTS WITH PSORIATIC ARTHRITIS ACROSS COUNTRIES WITH DIFFERENT GDP’S, AN ANALYSIS OF 429 PATIENTS FROM 13 COUNTRIES
15. POS0971 HOW DO CLINICAL AND SOCIOECONOMIC FACTORS IMPACT ON WORK DISABILITY IN EARLY AXIAL SPONDYLOARTHRITIS? FIVE-YEAR DATA FROM THE DESIR COHORT
16. POS0238 SICK LEAVE AND ITS PREDICTORS IN EARLY AXIAL SPONDYLOARTHRITIS: THE ROLE OF CLINICAL AND SOCIOECONOMIC FACTORS. FIVE-YEAR DATA FROM THE DESIR COHORT
17. OP0053 IMPACT OF CORRECTING CRP THRESHOLD ACCORDING TO BMI ON DIAGNOSIS, DISEASE ACTIVITY, INDICATION OF BIOLOGICAL TREATMENT AND PREDICTION OF THERAPEUTIC RESPONSE, IN PATIENTS SUSPECTED OF AXIAL SPONDYLOARTHRITIS. RESULTS FROM DESIR COHORT
18. POS1237 ALGORITHM IDENTIFYING CHRONIC INFLAMMATORY DISEASES TREATED BY BIOTHERAPY AND/OR TARGETED SYNTHETIC TREATMENTS IN OUTPATIENT CARE IN FRANCE: FEASIBILITY, PRELIMINARY RESULTS, AND IMPACT OF COVID-19
19. POS1236 IMPACT OF COVID-19 ON INITIATION AND RENEWAL OF BIOTHERAPIES AND TARGETED SYNTHETIC TREATMENTS
20. POS1030 EFFICACY OF UPADACITINIB IN PATIENTS WITH PSORIATIC ARTHRITIS STRATIFIED BY BASELINE SKIN SEVERITY: A SUBGROUP ANALYSIS OF TWO PHASE III TRIALS
21. FRI0348 PERSISTENCE OF SECUKINUMAB AND USTEKINUMAB IN PSORIATIC ARTHRITIS: A REAL-WORLD MULTICENTRIC COHORT OF 409 PATIENTS
22. OP0243 SERPINA3N LIMITS CARTILAGE DESTRUCTION IN OSTEOARTHRITIS BY INHIBITING MACROPHAGE-DERIVED LEUKOCYTE ELASTASE
23. AB0862 CONSENSUS STATEMENT ON INTRA-ARTICULAR INJECTIONS OF PLATELET-RICH PLASMA FOR THE MANAGEMENT OF KNEE OSTEOARTHRITIS
24. THU0437 SPECIFIC COMORBIDITIES ENHANCE MONOSODIUM URATE CRYSTAL DEPOSITION IN GOUT: A MULTICENTRE DUAL-ENERGY COMPUTED TOMOGRAPHY STUDY
25. THU0422 CALCIUM PYROPHOSPHATE CRYSTAL DEPOSITION WITHIN TOPHUS LOBULE: A FREQUENT ASSOCIATION OBSERVED IN LONG-TIME COURSE TOPHI
26. OP0036 METHOTREXATE AND RHEUMATOID ARTHRITIS ASSOCIATED INTERSTITIAL LUNG DISEASE
27. 2016 updated EULAR evidence-based recommendations for the management of gout
28. OP0088 Inflammation on MRI of The Spine Is Longitudinally Related To Disease Activity in Smokers but Not in Non-Smokers in Axial Spondyloarthritis: 2-Year Data from The Desir Cohort
29. THU0526 Efficacy and Safety of Febuxostat in 73 Gouty Patients with Stage 4/5 Chronic Kidney Disease: Result from A Retrospective 9 Multicenter Study
30. THU0396 Visceral Adipose Tissue and Cardiovascular Risk in Spondyloarthritis: Results from The DESIR and COMOSPA Cohorts
31. THU0106 Identification of Markers Associated with The Occurrence of Interstitial Lung Disease in Rheumatoid Arthritis Patients
32. THU0496 Combined Chondroitin Sulfate and Glucosamine is More Efficient than Celebrex in Reducing Serum Levels of COLL2-1, A Cartilage Degradation Biomarker, In Patients with Severe OA: Results from a Randomized, Double-Blind, Multicentric Clinical Trial
33. FRI0369 Health Utilities and Costs Among Early Spondyloarthritis Patients Treated and not Treated with TNFα Blockers: Estimates from the Desir Cohort
34. THU0369 Costs of Early Spondyloarthritis: Estimates from the First Three Years of the Desir Cohort
35. FRI0314 Assessment of the Ultrasonography's Efficiency as a Diagnostic Tool for Calcium Pyrophosphate Crystal Deposition Disease
36. SAT0035 Chondroprotective Effects of IL-6 Inhibition Through Blockade of the STAT3 Pathway
37. SAT0584 Impact of an Online Training on Skin Cancer Diagnosing in Rheumatologists, A Nationwide Randomized Web-Based Survey
38. PARE0022 First National Osteoarthritis Patients Survey in France: Patients Insights First!
39. SAT0532 Updated Eular Evidence-Based Recommendations for the Diagnosis of Gout
40. SAT0514 Does Hyperuricemia Worsen Pain and Function in Patients with Knee or Hip OA? Results from the Khoala Cohort
41. FRI0140 Developing Quality Criteria from the Assessments in Ankylosing Spondylitis Society (ASAS) and European League against Rheumatism (EULAR) Ankylosing Spondylitis Management Recommendations: towards Quantitative Definitions of “Non-Compliance”
42. THU0210 Impact of Components of the Metabolic Syndrome on Knee Osteoarthritis Progression in the SEKOIA Study
43. SAT0427 Multicentric Osteoarthritis Intervention Study with Sysadoa (MOVES): Effects of Combined Glucosamine Hydrochloride and Chondroitin Sulfate VS Celecoxib for Painful Knee Osteoarthritis
44. SAT0531 Updated Eular Evidence-Based Recommendations for the Management of Gout
45. SAT0418 The Serum Leptin/Adiponectin Ratio, A Useful Estimate of Insulin Resistance, is Associated with Clinical Symptoms in Hip Osteoarthritis: Results of the Population-Based French Khoala Cohort
46. SAT0544 Prevalence of Gout in the Adult Population of France in 2013
47. Adalimumab in patients with hand osteoarthritis refractory to analgesics and NSAIDs: a randomised, multicentre, double-blind, placebo-controlled trial
48. Identification of patients with gout: elaboration of a questionnaire for epidemiological studies
49. OP0234 Impact of a Nurse Led Program on the Management of Comorbidities in Rheumatoid Arthritis (RA). Results of a Prospective, Multicentre, Randomized, Controlled Trial (Comedra)
50. SAT0341 Strontium Ranelate Improves Osteoarthritis Symptoms Compared to Placebo in Patients with Knee OA - The Sekoia Study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.